Cargando…
Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common X-linked mutation that is more prevalent in African, Asian, Latin American and Mediterranean populations. Although most individuals are asymptomatic, exposure to certain food, drugs, or infections can trigger acute hemolytic anemia. Giv...
Autores principales: | Jamerson, Brenda D., Haryadi, T. Ho, Bohannon, Arline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IMSS. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275985/ https://www.ncbi.nlm.nih.gov/pubmed/32600868 http://dx.doi.org/10.1016/j.arcmed.2020.06.006 |
Ejemplares similares
-
Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin
por: Doustimotlagh, Amir Hossein, et al.
Publicado: (2021) -
Acquired Glucose-6-Phosphate Dehydrogenase Deficiency
por: Pes, Giovanni Mario, et al.
Publicado: (2022) -
Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection
por: Vick, Dan J.
Publicado: (2020) -
The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?
por: Jamerson, Brenda D., et al.
Publicado: (2020) -
Glucose-6 Phosphate Dehydrogenase Deficiency and Psychotic Illness
por: Singh, Vijender, et al.
Publicado: (2012)